405 Partnership talks between startups and corporates have been facilitated by R2GConnect, the global scouting platform

82 healthcare companies and investors have used R2GConnect, the global scouting and matchmaking platform for the digital health industry, to find the best startups for their open call (briefing opportunities). More than 5,100 digital health companies have joined the platform in the past 4 months. 405 partnership talks between startups and established healthcare companies have been facilitated. And this is just the beginning.

R2GConnect enables the healthcare industry to efficiently find partners and investment opportunities in the digital health space. Established healthcare companies are using various partnering formats such as investment funds, innovation hubs and accelerators to scout for and identify the right partners, adopt innovation, and manage partnerships with startups. More often than not, the challenge faced by the corporates is to receive high quality applications of digital health companies that match their program conditions, find the hidden champions and best in-class digital health companies to jointly drive the digital health agenda.

What are the reasons for partnership failures and what makes a successful partnership? How are companies organizing their digital activities? To examine the current partnership trends and best practices, what works and what doesn’t and why, R2G launched a study on “Startup-Corporate Partnerships in Digital Health 2023”. We invite you to take part in it and Have your say!

R2GConnect supports startup scouting in digital health. The platform allows corporate partners to directly invite startups from the database to view and apply to their open calls / briefings, to chat with them, and the recommendation engine can also suggest companies that best match their program requirements.

In 4 months after the launch and as of today, R2GConnect has grown its startups database to more than 5,100 digital health companies. (To learn more about the startup profiles – therapeutic areas, top product categories, please click here).

The preferred types of corporate partners by startups on R2GConnect are Investors (41%), Health insurance (34%), Hospitals (33%), Pharma companies (33%) and digital health companies (33%).

As 46% and 28% of companies’ product stages are in scaling and growth (paid pilot) respectively, not surprisingly the top preferred partnership areas by the startups are in commercialization (51%), funding (47%), piloting (31%), co-development (30%) and acquisition (18%).

To date the R2GConnect platform has partnered with 82 healthcare companies and investors and has published their customized open calls (briefing opportunities) targeting digital health innovators that support use cases and business models. Corporate clients’ must-have requirements (e.g., digital solution in Diabetes space, scale-up, ready to launch in the German market) and 3 deal-maker questions (e.g., What are you looking for in the partnership? Or Which studies show the outcome of your solution?) set the unique partnership scope and attract the right startups to apply.

More than 1,093 startups have expressed their interest in these partnership opportunities and have shared their portfolios. Of that, 405 startups have been invited for partnership talks.

17 new open calls (briefing opportunities) are published on R2GConnect for digital health innovators and startups to apply to.

VITA ACCELERATOR, the leading digital health program in Italy, for its 2023 Program (June – November 2023) has published 4 partnership opportunities.

BRIEFING 1: VITA Accelerator – Petrone Group: Digital Health Solutions for Telepharmacy, Pharmacy Distribution, Oral Care & Dentistry, Rare Diseases

Offer:

  • Corporate Partner of VITA Accelerator, Petrone Group, is offering the VITA startups an opportunity to do a pilot project in the course of the acceleration program.
  • Funding support: EUR 150,000 first ticket for all startups, of which EUR 90,000 in cash, plus EUR 400,000 up to EUR 2,000,000 cumulative follow-on for the best cases.
  • and much more

To learn more and apply, please click here

BRIEFING 2: VITA Accelerator – SIFI GROUP: Digital Solutions for Ophthalmology & Patient Education

Offer:

  • Corporate Partner of VITA Accelerator, SIFI Group, is offering the VITA startups an opportunity to do a pilot project in the course of the acceleration program.
  • Funding support: EUR 150,000 first ticket for all startups, of which EUR 90,000 in cash, plus EUR 400,000 up to EUR 2,000,000 cumulative follow-on for the best cases.
  • and much more

To learn more and apply, please click here

BRIEFING 3: VITA Accelerator – Zcube, Zambon Research Venture: Digital Solutions for Neurological Disorders, Respiratory & Women’s Health

Offer:

  • Innovation Partner of VITA Accelerator, Zcube, Zambon Research Venture, is offering the VITA startups an opportunity to do a pilot project in the course of the acceleration program.
  • Funding support: EUR 150,000 first ticket for all startups, of which EUR 90,000 in cash, plus EUR 400,000 up to EUR 2,000,000 cumulative follow-on for the best cases.
  • and much more

To learn more and apply, please click here

BRIEFING 4: Early-stage digital health startups, interested in the Italian market

Offer:

  • Funding support: EUR 150,000 first ticket for all startups, of which EUR 90,000 in cash, plus EUR 400,000 up to EUR 2,000,000 cumulative follow-on for the best cases.
  • Very practical and hands-on mentorship support on the deep digital health topics over 5 months hybrid program (no need to stay in Italy full time).
  • International startups can get soft-landing support in Italy if interested.

To learn more and apply, please click here

INNOVATION IN HEALTH (fmr EIT Health Germany) has published 8 partnership opportunities.

BRIEFING 1: Takeda: Digital Solutions for Clinical Decision Support Systems in IBD

Offer:

  • Commercial partnership.

To learn more and apply, please click here

BRIEFING 2: Beurer: Cuffless Blood Pressure Monitoring Solutions

Offer:

  • Commercial partnership.

To learn more and apply, please click here

BRIEFING 3: Qiagen: Digital Analytics Solutions to Improve Antibiotic Prescription Practices

Offer:

  • Commercial partnership.

To learn more and apply, please click here

BRIEFING 4: Siemens Healthineers: Cutting-edge Health Solutions for Developing Countries

Offer:

  • Commercial partnership.

To learn more and apply, please click here

BRIEFING 5: Aidian: Solutions to Simplify Nucleic Acid Extraction and Sample Preparation

Offer:

  • Commercial partnership.

To learn more and apply, please click here

BRIEFING 6: Abbott: Non-invasive Tool/Device for Monitoring the Health Status of the Gut Microbiome

Offer:

  • Commercial partnership.

To learn more and apply, please click here

BRIEFING 7: GSK: Early Disease Identification and Management Solutions for Systemic Lupus Erythematosus

Offer:

  • Commercial partnership.

To learn more and apply, please click here

BRIEFING 8: Grigori T. Popa University of Medicine and Pharmacy: Digital Companion to Improve Patient Experience in Romania

Offer:

  • Commercial partnership.

To learn more and apply, please click here

NUBENTOS, a leading API platform for digital health solutions, has published 5 partnership opportunities.

BRIEFING 1: Oncology Digital Health Solutions for a Commercial Partnership & Pilot Project

Offer:

  • Pilot project & a commercial partnership preparation (presentation, demo, etc).
  • Revenue sharing.
  • API connection support/onboarding.
  • Exposure to the Nubentos platform corporate clients.

To learn more and apply, please click here

BRIEFING 2: Mental Health Digital Health Solutions for a Commercial Partnership & Pilot Project

Offer:

  • Pilot project & a commercial partnership preparation (presentation, demo, etc).
  • Revenue sharing.
  • API connection support/onboarding.
  • Exposure to the Nubentos platform corporate clients.

To learn more and apply, please click here

BRIEFING 3: NLP-based Digital Health Solutions for a Commercial Partnership & Pilot Project

Offer:

  • Pilot project & a commercial partnership preparation (presentation, demo, etc).
  • Revenue sharing.
  • API connection support/onboarding.
  • Exposure to the Nubentos platform corporate clients.

To learn more and apply, please click here

BRIEFING 4: Digital Dermatology Solutions for a Commercial Partnership & Pilot Project

Offer:

  • Pilot project & a commercial partnership preparation (presentation, demo, etc).
  • Revenue sharing.
  • API connection support/onboarding.
  • Exposure to the Nubentos platform corporate clients.

To learn more and apply, please click here

BRIEFING 5: Digital Health Solutions supporting Pregnancy for a Commercial Partnership & Pilot Project

Offer:

  • Pilot project & a commercial partnership preparation (presentation, demo, etc).
  • Revenue sharing.
  • API connection support/onboarding.
  • Exposure to the Nubentos platform corporate clients.

To learn more and apply, please click here

Happy Matching and Good Luck!

Partnerships in the form of strategic alliances, joint ventures, and acquisitions are prevalent in the digital health industry. According to the views and opinions of key decision-makers who took part in R2G’s survey “The Global Digital Business Outlook – 2023”, digital health startups will continue to drive innovation. However, partnerships are the big thing in 2023. (To get your free copy of the whitepaper, click here)

If you are an Industry stakeholder looking for digital health startups, please book a demo session with Sorin Stircu, Partnerships Manager, R2GConnect by clicking on the Calendar

Since 2010, R2G has worked with healthcare companies and startups from around the world helping them to set up their partner strategy, find the right partner, develop win-win contracts, make pilots successful, integrate innovative digital services into the core offering of the incumbent and create new business lines. We are happy to talk and share our experience! For more information reach out to: [email protected]